Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Vera Therapeutics Inc Cl A (VERA)

Vera Therapeutics Inc Cl A (VERA)
26.51 x 1 29.55 x 4
Post-market by (Cboe BZX)
29.18 +1.72 (+6.26%) 02/18/25 [NASDAQ]
26.51 x 1 29.55 x 4
Post-market 29.18 unch (unch) 16:20 ET
Quote Overview for Tue, Feb 18th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
26.86
Day High
29.35
Open 27.84
Previous Close 27.46 27.46
Volume 2,316,600 2,316,600
Avg Vol 1,021,200 1,021,200
Stochastic %K 14.11% 14.11%
Weighted Alpha -41.48 -41.48
5-Day Change -6.70 (-18.67%) -6.70 (-18.67%)
52-Week Range 25.99 - 51.61 25.99 - 51.61
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,738,850
  • Shares Outstanding, K 63,323
  • Annual Sales, $ 0 K
  • Annual Income, $ -95,990 K
  • EBIT $ -145 M
  • EBITDA $ -149 M
  • 60-Month Beta 1.11
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.51

Options Overview Details

View History
  • Implied Volatility 62.67% ( -14.27%)
  • Historical Volatility 83.16%
  • IV Percentile 26%
  • IV Rank 30.51%
  • IV High 96.02% on 10/16/24
  • IV Low 48.03% on 12/06/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 1,417
  • Volume Avg (30-Day) 419
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 9,781
  • Open Int (30-Day) 4,107

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.83
  • Number of Estimates 6
  • High Estimate -0.62
  • Low Estimate -0.90
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -43.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.99 +12.27%
on 02/14/25
Period Open: 33.37
40.47 -27.90%
on 01/30/25
-4.19 (-12.56%)
since 01/17/25
3-Month
25.99 +12.27%
on 02/14/25
Period Open: 44.81
51.27 -43.09%
on 12/02/24
-15.63 (-34.88%)
since 11/18/24
52-Week
25.99 +12.27%
on 02/14/25
Period Open: 45.96
51.61 -43.46%
on 11/13/24
-16.78 (-36.51%)
since 02/16/24

Most Recent Stories

More News
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 29.18 (+6.26%)
Stocks Settle Higher as Megacap Tech Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.92%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.59%. March E-mini S&P...

GOOGL : 183.77 (-0.79%)
AMAT : 172.00 (+1.65%)
PCAR : 106.54 (+0.55%)
AAPL : 244.47 (-0.05%)
ADI : 220.22 (+2.61%)
DDOG : 130.63 (-0.29%)
MDB : 298.52 (+3.07%)
TXN : 186.46 (+1.87%)
IVZ : 18.52 (+0.11%)
$IUXX : 22,164.61 (+0.23%)
ASML : 744.22 (-0.98%)
ZNH25 : 108-265 (-0.01%)
Stocks Edge Higher as Megacap Tech and Software Stocks Climb

The S&P 500 Index ($SPX ) (SPY ) today is up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.83%. March E-mini S&P futures (ESH25...

GOOGL : 183.77 (-0.79%)
AMAT : 172.00 (+1.65%)
PCAR : 106.54 (+0.55%)
AAPL : 244.47 (-0.05%)
ADI : 220.22 (+2.61%)
DDOG : 130.63 (-0.29%)
MDB : 298.52 (+3.07%)
TXN : 186.46 (+1.87%)
IVZ : 18.52 (+0.11%)
$IUXX : 22,164.61 (+0.23%)
ASML : 744.22 (-0.98%)
ZNH25 : 108-265 (-0.01%)
Stocks Mixed as Tech Stabilizes from Monday’s Rout

The S&P 500 Index ($SPX ) (SPY ) today is down -0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.07%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.09%. March E-mini S&P futures (ESH25...

AMAT : 172.00 (+1.65%)
PCAR : 106.54 (+0.55%)
AAPL : 244.47 (-0.05%)
ADI : 220.22 (+2.61%)
TXN : 186.46 (+1.87%)
IVZ : 18.52 (+0.11%)
$IUXX : 22,164.61 (+0.23%)
ASML : 744.22 (-0.98%)
ZNH25 : 108-265 (-0.01%)
CIEN : 89.65 (-0.17%)
ESH25 : 6,151.50 (+0.08%)
NCLH : 27.20 (+3.11%)
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 29.18 (+6.26%)
Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor

VERA : 29.18 (+6.26%)
Vera Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

VERA : 29.18 (+6.26%)
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 29.18 (+6.26%)
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VERA : 29.18 (+6.26%)
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer

VERA : 29.18 (+6.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Vera Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 32.56
2nd Resistance Point 30.95
1st Resistance Point 30.07
Last Price 29.18
1st Support Level 27.58
2nd Support Level 25.97
3rd Support Level 25.09

See More

52-Week High 51.61
Fibonacci 61.8% 41.82
Fibonacci 50% 38.80
Fibonacci 38.2% 35.78
Last Price 29.18
52-Week Low 25.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion